Full-Time

Senior Finance Manager

Enterprise WWPP and R&D Finance

Updated on 6/25/2026

GE Healthcare

GE Healthcare

1-10 employees

Imaging, monitoring, and healthcare IT solutions

Compensation Overview

$154k - $231k/yr

+ Performance Based Incentive + Long Term Incentives

No H1B Sponsorship

Chicago, IL, USA + 1 more

More locations: Waukesha, WI, USA

In Person

Category
Finance & Banking
Required Skills
Power BI
Oracle Hyperion
Excel/Numbers/Sheets
PowerPoint/Keynote/Slides
Requirements
  • Bachelor’s degree in Finance, Accounting, or Business Administration; 8+ years financial experience (or 12+ years without a degree)
  • Strong FP&A background with group‑level exposure and senior leadership interaction
  • Experience leading complex consolidations and cross‑functional programs
  • Advanced Excel and PowerPoint; experience with Essbase/Hyperion, Power BI and PPM (Portfolio Project Management) tools
  • Exceptional communication skills; ability to explain complex topics clearly
  • Strong critical thinking skills and proactively assess risks and opportunities on the portfolio
  • Ability to operate in a global, matrixed environment and navigate ambiguity
Responsibilities
  • Supports the annual WWPP review cycle with CEO/CFO; closely partner with Segment Finance, Group FP&A, CTOs, and regional leaders.
  • Govern WWPP policy, finance parameters, and NPI business case frameworks.
  • Drive 100% compliance with PPM tool (Portfolio Project Management) as the single source of truth for NPI tracking.
  • Scale R&D Power BI dashboards to enable ROI‑based program ranking and portfolio optimization.
  • Perform regular audits to drive governance and full compliance of WWPP finance policy.
  • Partner with Group FP&A to integrate WWPP outputs into LTS, Budget, and BOD review cycles.
  • Use the lean principles to improve current WWPP processes and operating mechanism and drive the governance to improve the qualitative output.
  • Collaborate with Segment R&D Finance leaders to consolidate global R&D Financials, develop the trends, story-telling and support decision making (~$2B across 300+ programs).
  • Provide Global R&D spend and NPI updates for both Board level reviews and Investor relations team, as appropriate.
  • Lead three L0 NPI innovation metrics at company level - NPI Vitality, L0 Lighthouse NPI Orders and Launch Bowler
  • Drive standard work and automation for weekly/monthly Innovation KPIs by establishing consistent reporting processes, automating data flows, and strengthening governance for reliable enterprise metrics.
  • Support ongoing enhancements to the IMS NPI dashboard ecosystem by integrating new datasets, improving usability and visual clarity, and driving broader adoption that expand usage, insights, and business value.
  • Champion standardization, lead transformation, and capability building across STO finance and operations (standard work/guidance, process consistency, targeted transformation initiatives to improve efficiency, reduce manual work and enhance output quality.
  • Strengthen STO-specific planning, program structure and executive rigor through PPM standardization and tool enhancements across the enterprise and alignment with the operating teams.
  • Develop forward-looking analytics and forecasting capabilities in Power BI and enterprise tools to move from rear-view reporting to forward-looking forecasting by unlocking new capabilities in automated variance analysis, scenario modeling and improved real-time performance tracking.
  • Support STO planning cycles (WWPP, LTS, Budget) by providing R&D investment inputs and analysis, and preparing leadership review materials.
  • Partner with Group FP&A and Strategy to align R&D investment data with enterprise planning calendars, milestones, and deliverables.
  • Translate bottoms‑up R&D program details into financial plans, targets, and investment views to inform broader STO planning outputs and materials.
Desired Qualifications
  • MBA, CPA, or completion of GE/GEHC finance leadership programs
  • LEAN or Six Sigma experience with demonstrated process improvements
  • Analytical, critical thinker with strategic problem‑solving capability
  • Influential leader who drives change and standardization across stakeholders
  • High integrity, resilience, and comfort in innovation‑driven environments

GE Healthcare Systems provides medical technologies and digital infrastructure to improve diagnosis, treatment, and monitoring of patients. Its products include imaging systems, mobile diagnostic devices, patient monitoring tools, and healthcare IT software that work together as hardware, software, and services to support hospitals, clinics, and researchers. The company differentiates itself with a large, integrated ecosystem, strong focus on AI analytics, and a global service network backed by substantial R&D investment. Its goal is to improve patient outcomes and the efficiency of healthcare delivery by enabling accurate diagnoses, effective treatments, and scaled operations.

Company Size

1-10

Company Stage

IPO

Headquarters

Chicago, Illinois

Founded

1892

Your Connections

People at GE Healthcare who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • FDA-cleared MIM Contour ProtégéAI+ 2.0 accelerates radiation oncology planning.[1]
  • DeepHealth breast screening integration improved detection 21% in U.S. studies.
  • Intelerad strengthens cloud enterprise imaging and adjacent digital infrastructure.
  • Sonic DL and helium-free MRI can boost workflow speed and operating economics.
  • Record backlog and 2025 revenue of $20.6 billion support future software and services growth.

What critics are saying

  • Memory-chip, oil, and freight inflation already forced 2026 profit guidance lower.
  • Intelerad integration can delay cloud imaging revenue and distract sales execution.
  • FDA or clearance delays can slow AI product refreshes and MRI adoption.

What makes GE Healthcare unique

  • GE HealthCare spans imaging, ultrasound, patient care, and pharmaceutical diagnostics.[1]
  • Its 2023 spin-off created a focused, publicly traded healthcare technology company.[1]
  • The company combines hardware, software, and services across 100-plus countries.[1][3]

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

401(k) Retirement Plan

401(k) Company Match

Tuition Reimbursement

Relocation Assistance

Company News

The Associated Press
Apr 9th, 2026
GE HealthCare integrates bkActiv ultrasound with Medtronic Stealth AXiS for real-time cranial surgery navigation

GE HealthCare has announced a digital integration between its bkActiv intraoperative ultrasound system and Medtronic's Stealth AXiS surgical navigation system, now commercially available for cranial procedures. The integration allows neurosurgeons to use bkActiv as a plug-and-play real-time visualisation solution during procedures. The system addresses "brain shift", a natural movement of the brain during surgery that reduces pre-surgical image accuracy. bkActiv provides live ultrasound images alongside pre-operative MRI or CT scans on the Stealth AXiS system, recently cleared by the FDA for cranial procedures in the United States. Features include sterilisable transducers, sensitive colour Doppler for blood flow visualisation, and remote control capability from the sterile field. The companies will showcase the integration at the American Association of Neurological Surgeons Annual Scientific Meeting in May 2026.

Business Wire
Mar 25th, 2026
GE HealthCare unveils photon-counting CT and ReadyFix fleet management at ACC.26

GE HealthCare is showcasing its cardiology portfolio at ACC.26, featuring AI-enabled imaging technologies and software solutions addressing cardiovascular disease, which kills over 900,000 Americans annually. The company received US FDA 510(k) clearance for Photonova Spectra, a photon-counting CT system with proprietary Deep Silicon detectors designed to provide ultra-high-definition cardiac imaging and improved plaque characterisation. GE HealthCare introduced ReadyFix fleet management solution for MAC VU360 ECG workstations, enabling remote diagnostics and software deployment to optimise device uptime. The company also announced a US collaboration with Gentuity, connecting customers with HF-OCT and Vis-Rx PRIME Micro-Imaging Catheter for enhanced coronary procedure visualisation. The $20.6 billion company serves patients globally with imaging, diagnostics and AI solutions across the cardiology care pathway.

Business Wire
Mar 23rd, 2026
GE HealthCare's photon-counting CT Photonova Spectra receives FDA clearance

GE HealthCare has received FDA 510(k) clearance for Photonova Spectra, a photon-counting computed tomography system powered by its Deep Silicon detector technology. The system directly counts individual photons and measures their energy, enabling higher spectral and spatial resolution compared to conventional CT systems that first convert X-rays into visible light. Photonova Spectra features 8-bin energy resolution, wide detector coverage and rapid 0.23-second rotation speed, supporting fast acquisition and detailed visualisation across multiple clinical specialties. The system automatically captures spectral and ultra-high definition spatial data simultaneously without requiring special protocols. The technology incorporates NVIDIA accelerated computing to process up to 50 times more data than conventional CT systems. GE HealthCare is collaborating with institutions including UW-Madison and Stanford Medicine to explore clinical applications and imaging protocols.

Yahoo Finance
Mar 17th, 2026
GE HealthCare appoints Stryker CEO Kevin Lobo to board of directors

GE HealthCare has appointed Kevin Lobo, chair and CEO of Stryker Corporation, to its board of directors effective 13 March. Lobo brings over 25 years of medical technology, operational and financial leadership experience to the role. Lobo has served as Stryker's CEO since October 2012 and board chair since July 2014. Previously, he held leadership positions at Johnson & Johnson, including president of Ethicon Endo Strategy, and at chemical and pharmaceutical company Rhône-Poulenc. His early career included finance roles at KPMG, Unilever and Kraft Canada. GE HealthCare chairman H. Lawrence Culp said Lobo's clinical expertise and track record of driving innovation would strengthen the board as the company pursues growth priorities in personalised, connected healthcare.

Yahoo Finance
Mar 16th, 2026
Arthur J. Gallagher leads with 17.9% revenue growth while Grand Canyon Education and GE HealthCare struggle

Arthur J. Gallagher, an insurance brokerage and consulting firm, stands out amongst cash-producing stocks with a 12.8% trailing 12-month free cash flow margin. The company has demonstrated strong revenue growth of 17.9% annually over the past two years and earnings per share growth of 17.7% annually over five years, outperforming peers. In contrast, Grand Canyon Education faces challenges with underwhelming student numbers and modest earnings growth of just 7.2% annually over five years, despite a 21.6% free cash flow margin. GE HealthCare also struggles with weak 2.7% annual revenue growth over two years and limited organic expansion. Arthur J. Gallagher, operating in approximately 130 countries, provides insurance brokerage, reinsurance and consulting services globally.